FDA's advice on risk of fungal infections with TNF-α inhibitors

Author：  

Publisher： Adis International

ISSN： 0114-9954

Source： Reactions Weekly, Vol.1, Iss.1219, 2008-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

TNF-α inhibitors and SLE

By  

Reactions Weekly, Vol. 1, Iss. 1255, 2009-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Legionella and Listeria infections with TNF-α blockers

By  

Reactions Weekly, Vol. 1, Iss. 1369, 2011-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

TNF-α inhibitors: Whipple's disease: 5 cases

By  

Reactions Weekly, Vol. 1, Iss. 1317, 2010-01 ,pp. : 42-42

Adis International

Access to resources Recommend Favorite

TNF-α Inhibitors and Leukaemia: International Pharmacovigilance Reports

By Meyboom Ronald H.B.   Star Kristina  

Drug Safety, Vol. 31, Iss. 5, 2008-01 ,pp. : 445-447

Adis International

Access to resources Recommend Favorite

Free radicals and endothelial dysfunction: Potential positive effects of TNF-α inhibitors

By Murdaca Giuseppe   Span? Francesca   Cagnati Paola   Puppo Francesco  

Redox Report, Vol. 18, Iss. 3, 2013-05 ,pp. : 95-99

Maney Publishing

Access to resources Recommend Favorite